Fsn-0306

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFsn-0306
Drug Alias Nameprotease inhibitor (Fusion Antibodies)cysteine protease inhibiting antibody (Fusion Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionCathepsin B inhibitors
TargetsCathepsin B
Therapy Area/IndicationsMultiple MyelomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFusion Antibodies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFusion AntibodiesFusion Pharma Llc
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A